HENDERSON, Nev., Sept. 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) (XASE: VNRX) (together with affiliates "Volition"), a multi-national epigenetics company, as part of the Government-funded DETECSEPS Consortium in France, today shares further details about the...
Hence then, the article about volitionrx shares further details and video of the detecseps program launch in france was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France )
Also on site :
- Insider One Introduces Agent One™, the Self-Optimizing Intelligence System for Autonomous Customer Engagement
- Chunghwa Telecom Receives Frost & Sullivan's 2026 Taiwanese Customer Value Leadership Recognition for AI-Powered Customer Services
- OpenAI discloses six new AI misalignment incidents of 'rogue' behaviour